Incidence and Nature of Antidepressant Discon...

Interview with Amy N. Cohen, PhD, and Matthew Chinman, PhD, authors of Tailored Weight Loss Programs for Adults With Serious Mental Illness: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Tailored Weight Loss Programs for Adults With Serious Mental Illne ...  Show more

Interview with Declan M. McLoughlin, PhD, author of Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Serial Ketamine Infusions as Adjunctive Therapy to Inpatien ...  Show more

In this episode, my guest is Dr. Matthew Hill, Ph.D., a professor of cell biology and anatomy at the Hotchkiss Brain Institute at the University of Calgary and an expert on the biology of cannabis. We discuss how cannabis affects the brain to produce its psychoactive effects (fee ...  Show more

On today's episode of of the podcast, I will discuss marijuana use and how it affects mental health with Daniel Binus, the chief psychiatrist at Beautiful Minds, near Sacramento, California. Also joining us is a third-year medical student, Victoria Agee. There are a few reasons w ...  Show more

The neuroscience behind the benefits and risks of marijuana, explained.

Splintered legislature, evolving taboos, and new forms of consumption have created a fragmented market for cannabis, and made it challenging for scientists to research its effects on our brains and ...

Le 07 octobre dernier le décret autorisant l’expérimentation du cannabis à usage thérapeutique paraissait au journal officiel. En gélule, en huile mais aussi en fleurs séchées à vaporiser, c’est bien du cannabis traditionnel, à teneur régulé en THC qui sera utilisé.

L'e ...